RxDoctor Payments Data

Maren Shaw, MD

Dermatology · Washington, DCNPI 1205039922

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.1% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations.

$7,060in general payments, 2019–2025

Across 244 payments — averaging $28.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$886
  • AbbVie$789
  • Lumenis BE Inc$673
  • Sanofi$644
  • Dermavant Sciences, Inc.$464
  • Regeneron Healthcare Solutions, Inc.$371
  • plus $3K from 24 others

What the payments were for

  • Food & beverage$6,50492%
  • Education$5578%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,060 in reported general payments places this provider in the 60th percentile of 73 dermatology providers in District of Columbia.

See all dermatology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$616,015
Medicare patients
1,028
Services billed
6,660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Unoready PenSecukinumab13$114,735
Tacrolimus30$8,169
Clobetasol Propionate74$5,155
Pimecrolimus16$4,446
Fluorouracil44$2,882
Ketoconazole126$2,038
Metronidazole30$1,931
Triamcinolone Acetonide114$1,456
Fluocinonide21$939
Mupirocin58$603
Ciclopirox12$511
Ammonium Lactate30$504
Doxycycline Hyclate42$487
Betamethasone Valerate17$458
Hydrocortisone58$402

Paid to pharmacies, not to this prescriber.

Other dermatology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →